Super happy and proud about the publication of the first authored paper of my #PhD student Nasim Nakhost Lotfi in RMD Open 😊👏🎈

How reliable can we utilise different #PROMs in #apps when assessed in different frequencies?
Have a look 👇

rmdopen.bmj.com/cgi/content/...

#Rheum
#ehealth
#arthritis

@mdr-ra-project.bsky.social GA has brought together our consortium in the heat of #Verona
These 2 days enabled clarity on setting the tracks to achieve our goals
Endotypes of #D2T #RA
Development of a clever #CDSS
😊 to co-lead the clinical deep phenotyping together with @drpetermandl.bsky.social

2 weeks ago #EULAR2025 closed. A congress full of education and innovation spread over 4 days.
Project Meetings (#Squeeze #Stratafit
EULAR Meetings (qoc #bigdata #atrisk)
2 lectures on #AIforIA & #PRPinvolvement
together with many conversations / exchanges and smiles filled my congress. ❤️ Thanks

Christina Wettengl delivered an excellent oral presentation on the #ContextualAnalysis for the Care Model development in Switzerland for @squeezeproject.bsky.social #EULAR2025

#EULAR2025 also offered the possibilty to come together for scientific project meetings.
The @squeezeproject.bsky.social
Wp8 team spent very productive 2 hours on steering the trajectories for our #adherence and #implementation ideas

One of the most crucial sessions for research in #rheumatology just started:

How to involve patients in your #research

💢Get your insights in #collaborativeresearch now
🤝
#EULAR2025
#PRP

Fantastic to see Sladjana, a STRATA-FIT patient research partner, presenting about the project and the evaluation of PRP involvement - partnership, communication, and support are critical #eular2025

Evaluation of the Torque Teno Virus as a potential immunologic marker in #RheumatoidArthritis presented by Daniel Mrak today. Interested in the potential of TTV as an "immunometer"? Follow @ttvguidetx.bsky.social on TTV-guided dosing of immunosuppressive drugs in kidney transplant recipients. #TTV

Very happy to see #TTV having the opportunity to be presented and discussed in the realm of #rheumatology
Great work of Daniel Mrak and interdisciplinary collaboration😊
POS0914
@squeezeproject.bsky.social
#EULAR2025

Very intense phenotyping of patients with RA in Remission double checked with #US comparing people tapering & stopping DMARD treatment with those continuing for the occurrence of #flare.
#spatialtranscriptomics #RNAseq #synovialbiopsy by Stefano Alivernini #EULAR2025

Join by at the poster presentation of Claudia Hana on trajectories of #MTX use in patients with RA this afternoon at m348
@squeezeproject.bsky.social
#EULAR2025

ICYMI, the inspiration for our April cover—Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial bit.ly/3GpCl9X

Plus linked Comment bit.ly/4ivhVKo
#Medsky #Rheumsky

Thank you @gregorbond.bsky.social for enriching the frame of biomarkers in the field of #rheumatoidarthritis.
#TTV as biomarker of immunosuppression has for sure different facets.
I always enjoy the #interdisciplinary exchange

The last two days were dedicated to intense discussions, phrasing Update recommendations for large vessel #vasculitis
- #LVV -
Combining expertise from 15 countries
Thanks to the leads C. Mukhtyar, B. Hellmich & E. Nikiphorou & the marvelous fellows @drminidey.bsky.social D. Misra A. Bartoletti

#Digitalrheumatology days update
#RCT including people with inflammatory #arthritis and #SLE subjecting to either #CBT or leaflet information about #depression and anxiety
CBT was integrated into a 90 days program delivered via a smartphone app.
Promising results presented by @johannesknitza 👇

These days the #Digital #Rheumatology days are on again in #Berlin. #7th Edition
An interdisciplinary audience from 19 countries come together. 🌐
I had the pleasure to provide an update of developments over the past year in #digitalhealth #ehealth
New insights and productive exchange 💢

A map of Europe highlighting the locations of six new AI factories established by the European Union. The factories are marked with icons and are distributed as follows: Selected in December 2024 (blue markers): MIMER AI Factory at the University of Linköping, Sweden, ITALIA AI Factory at CINECA, Italy; BSC AI Factory at the Barcelona Supercomputing Centre, Spain; HammerHAI at the University of Stuttgart, Germany; Meluxina-AI at the LuxPriovide, Luxembourg; Pharos at GRNET, Greece. Selected in March 2025 (purple markers): AI2F in Bruyères-le-Châtel, France; JAIF in Jülich, Germany, PIAST AIF in Poznań, Poland; AIAAT in Vienna, Austria, SLAIF in Maribor, Slovenia; BRAIN++ in Sofia, Bulgaria. The map uses shades of purple to indicate the countries where the factories are located and includes EU branding at the top.

Say hello to Europe's six new new AI Factories:

🇦🇹 AI:AT
🇧🇬 BRAIN++
🇫🇷 AI2F
🇩🇪 JAIF
🇵🇱 PIAST
🇸🇮 SLAIF

These factories will help startup, small and medium companies develop AI models using top supercomputing power, data, and talent ↓

europa.eu/!F6KGPG

Peripheral Biomarker Signatures in Rheumatoid Arthritis-Associated Interstitial Lung Disease. Graphical abstract created with BioRender

Cross-sectional study in the VA rheumatoid arthritis registry identified 8 peripheral blood biomarkers that could improve RA-interstitial lung disease risk stratification beyond clinical risk factors

In A&R
acrjournals.onlinelibrary.wiley.com/doi/10.1002/...
#Medsky #Pulmsky

International women's day
8th of March
developments in steps
Studying #medicine for women in Vienna was possible only since the start of the 20th century
Dr. Anna Fischer-Dückelmann underwent med school in switzerland before publishing the book 👇 a novelty back then and reprinted over decades

Comparative Effectiveness and Safety of the JAK Inhibitors and Biologic Disease-Modifying Antirheumatic Drugs in Treating Children With Nonsystemic Juvenile Idiopathic Arthritis: A Bayesian Meta-Analysis of Randomized Controlled Trials. Graphical abstract created with BioRender

Bayesian meta-analysis of RCTs compared efficacy and safety of JAK inhibitors vs bDMARDs for nonsystemic forms of juvenile idiopathic arthritis. Results showed no significant difference in efficacy and safety outcomes among the treatment options

In ACROR
doi.org/10.1002/acr2...
#Medsky

FIRST #EULAR Quality of Care webinar
"Diagnosis and Treatment of Giant Cell Arteritis"!

Wednesday, 19 February 2025, 17:00 -18:00 CET

This one touches on the products of EULAR aiming to aid #rheumatologists in different aspects around #GCA!

Register here👉 lnkd.in/dct7mYAC

Humanitas University coordinates a European project on multi-drug resistant rheumatoid arthritis - Hunimed The MDR-RA (Multi-Drug Resistance in Rheumatoid Arthritis) project has officially started: it’s an international research initiative, with a total budget

Exciting news!🎉The official #HorizonEurope #MDRRAProject press release has been published by our coordinator, Humanitas University!🌍Learn more about how we’re tackling multi-drug resistant #RA through groundbreaking #research and #collaboration. Stay tuned for updates! #MDRRA #HorizonEU #EUProject